B of A Securities Downgrades National Health Investors to Underperform, Lowers Price Target to $67

Benzinga · 1d ago
B of A Securities analyst Joshua Dennerlein downgrades National Health Investors (NYSE:NHI) from Buy to Underperform and lowers the price target from $86 to $67.